Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

International Assets Investment Management LLC Has $2.65 Million Stock Holdings in Bristol Myers Squibb Company (NYSE:BMY)

Proactive Wealth Strategies LLC Makes New $2.32 Million Investment in Bristol Myers Squibb Company (NYSE:BMY)

Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis

The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types

Chapin Davis Inc. Boosts Stake in Bristol Myers Squibb Company (NYSE:BMY)

Oppenheimer & Co. Inc. Has $14.79 Million Stock Holdings in Bristol Myers Squibb Company (NYSE:BMY)

Oppenheimer Asset Management Inc. Purchases 15,934 Shares of Bristol Myers Squibb Company (NYSE:BMY)

Manning & Napier Advisors LLC Sells 34,284 Shares of Bristol Myers Squibb Company (NYSE:BMY)

ICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients | Morningstar

GAM Holding AG Lowers Position in Bristol Myers Squibb Company (NYSE:BMY)

Castleview Partners LLC Buys 12,703 Shares of Bristol Myers Squibb Company (NYSE:BMY)

Cantor Fitzgerald Investment Advisors L.P. Cuts Stock Position in Bristol Myers Squibb Company (NYSE:BMY)

Retirement Systems of Alabama Sells 88,683 Shares of Bristol Myers Squibb Company (NYSE:BMY)

Envestnet Portfolio Solutions Inc. Sells 66,286 Shares of Bristol Myers Squibb Company (NYSE:BMY)

Robertson Stephens Wealth Management LLC Sells 963 Shares of Bristol Myers Squibb Company (NYSE:BMY)

United Advisor Group LLC Sells 7,285 Shares of Bristol Myers Squibb Company (NYSE:BMY)

PSCI Endorses My Green Lab's Converge Supplier Initiative To Cut Scope 3 Emissions in Pharma | Morningstar

State of Alaska Department of Revenue Has $20.69 Million Stake in Bristol Myers Squibb Company (NYSE:BMY)

Kingswood Wealth Advisors LLC Acquires 28,129 Shares of Bristol Myers Squibb Company (NYSE:BMY)

Inscription Capital LLC Buys New Position in Bristol Myers Squibb Company (NYSE:BMY)

Bristol-Myers Squibb to Issue Quarterly Dividend of $0.62 (NYSE:BMY)

Company Website: https://www.bms.com PRINCETON, N.J. -- (B

Five Oceans Advisors Purchases New Shares in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Expands in Cancer Care With $1.35B OncoACP3 Deal

San Luis Wealth Advisors LLC Sells 99,229 Shares of Bristol-Myers Squibb (NYSE:BMY)

ADC cancer drugs: Pfizer, AstraZeneca, Merck bet on chemo replacement

Bristol-Myers Squibb (NYSE:BMY) Stake Boosted by Demars Financial Group LLC

Kercheville Advisors LLC Has $549,000 Holdings in Bristol-Myers Squibb (NYSE:BMY)

Grimes & Company Inc. Reduces Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Dynamic Advisor Solutions LLC Raises Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers Squibb Presents Promising Blood Cancer Drug Data at EHA Congress

10 Best Stocks to Buy For Beginners Now

QRG Capital Management Inc. Purchases 43,977 Shares of Bristol-Myers Squibb (NYSE:BMY)

Good Life Advisors LLC Buys 10,404 Shares of Bristol-Myers Squibb (NYSE:BMY)

Q1 EPS Estimate for Bristol-Myers Squibb Boosted by Analyst

Mn Services Vermogensbeheer B.V. Sells 58,400 Shares of Bristol-Myers Squibb (NYSE:BMY)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Lowers Holdings in Bristol-Myers Squibb (NYSE:BMY)

7,137 Shares in Bristol-Myers Squibb (NYSE:BMY) Bought by McBroom & Associates LLC

Bristol-Myers Squibb (BMY) Announces Positive Data From the Pivotal Phase 3 POETYK PsA-1 Trial

Jim Cramer on Bristol Myers: "We Need to See That Stock Back Up at $60" - Insider Monkey

Avaii Wealth Management LLC Acquires 67,221 Shares of Bristol-Myers Squibb (NYSE:BMY)

NorthCrest Asset Manangement LLC Cuts Stake in Bristol-Myers Squibb (NYSE:BMY)

Zhang Financial LLC Has $390,000 Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Rockland Trust Co. Reduces Stake in Bristol-Myers Squibb (NYSE:BMY)

Secondary analysis of the EMPACT-MI trial reveals cardiovascular-kidney efficacy and safety of empagliflozin after acute myocardial infarction

Education of healthcare professionals to improve guideline adherence in atrial fibrillation: the STEEER-AF cluster-randomized clinical trial

Keeping the immuno-oncology flame burning

Fort Washington Investment Advisors Inc. OH Buys 18,876 Shares of Bristol-Myers Squibb (NYSE:BMY)

Davis Investment Partners LLC Boosts Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

BioNTech to acquire CureVac in $1.25 billion all-stock deal

Wedge Capital Management L L P NC Sells 511,384 Shares of Bristol-Myers Squibb (NYSE:BMY)

In the clinic for June 12, 2025 | BioWorld

Curbstone Financial Management Corp Boosts Stake in Bristol-Myers Squibb (NYSE:BMY)

Franklin Street Advisors Inc. NC Buys 8,191 Shares of Bristol-Myers Squibb (NYSE:BMY)

CX Institutional Sells 8,445 Shares of Bristol-Myers Squibb (NYSE:BMY)

Farther Finance Advisors LLC Acquires 13,372 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb To Present At Goldman Sachs Global Conference; Webcast At 10:00 AM ET

Philochem, BMS ink $1.35B deal for prostate cancer candidate OncoACp3 | BioWorld

TERN-501 monotherapy and combination therapy with TERN-101 in metabolic dysfunction-associated steatohepatitis: the randomized phase 2a DUET trial

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties | Morningstar

Handelsbanken Fonder AB Purchases 6,956 Shares of Bristol-Myers Squibb (NYSE:BMY)

224,806 Shares in Bristol-Myers Squibb (NYSE:BMY) Bought by Nepsis Inc.

Abacus FCF Advisors LLC Grows Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Park Avenue Securities LLC Acquires 9,973 Shares of Bristol-Myers Squibb (NYSE:BMY)

CHICAGO TRUST Co NA Acquires 7,890 Shares of Bristol-Myers Squibb (NYSE:BMY)

Toth Financial Advisory Corp Grows Holdings in Bristol-Myers Squibb (NYSE:BMY)

Greystone Financial Group LLC Makes New $9.76 Million Investment in Bristol-Myers Squibb (NYSE:BMY)

Vest Financial LLC Increases Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Capital Investment Advisors LLC Has $14.01 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by UMB Bank n.a.

Bristol-Myers Squibb (NYSE:BMY) Stock Holdings Cut by Bourne Lent Asset Management Inc.

Procyon Advisors LLC Purchases 9,763 Shares of Bristol-Myers Squibb (NYSE:BMY)

Hennion & Walsh Asset Management Inc. Has $1.06 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Receives Consensus Recommendation of "Hold" from Brokerages

Wall Street Zen Downgrades Bristol-Myers Squibb (NYSE:BMY) to Buy
Was Jim Cramer Right About Bristol-Myers Squibb Co. (BMY)?

Denovo Biopharma Announces Formation of Neuroscience Scientific Advisory Board to Advance Precision Medicine in Depression | Morningstar

Generali Investments Management Co LLC Increases Stake in Bristol-Myers Squibb (NYSE:BMY)

Genetic mutation identified as key factor in immunotherapy resistance for melanoma

RFG Advisory LLC Buys 11,208 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Merit Financial Group LLC

NBC Securities Inc. Has $623,000 Holdings in Bristol-Myers Squibb (NYSE:BMY)

Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma

TruWealth Advisors LLC Buys New Stake in Bristol-Myers Squibb (NYSE:BMY)

Contravisory Investment Management Inc. Acquires 127,239 Shares of Bristol-Myers Squibb (NYSE:BMY)

Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial

Undetectable Disease Status in Myeloma Similar With Drug Therapy, Transplantation

Truist Lifts BioNTech (BNTX) Price Target After New Partnership
Bristol-Myers Squibb (NYSE:BMY) Collaborates With BioNTech For Antibody Development In Cancer Treatment

Bristol-Myers Squibb (NYSE:BMY) Stake Raised by Viking Fund Management LLC

Fulton Bank N.A. Reduces Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by LVW Advisors LLC

Why BioNTech SE (BNTX) Skyrocketed On Monday

Bristol-Myers Squibb Company and BioNTech SE Partner to Advance Next-Gen Cancer Therapies

Adding Neoadjuvant Nivolumab to Chemo Improved Survival in Resectable NSCLC

Bristol Myers' cancer deal is promising, but doesn't change our stance on stock yet

Bristol-Myers (BMY) Licenses BioNTech's Immunotherapy in $11 billion Deal

Biontech trades half of bispecific BNT-327 to BMS for potential $11B+ | BioWorld
BristolMyers News
Latest news
Show more
Morning Note: Mideast Tensions Drive Oil & Gold Volatility; Tesla Rolls Out Robotaxi

Global tensions impacted crypto market: BTC over $100K, Cardano around $0.54